Funds trio key shareholders in Open Orphan merger firm
A trio of London funds have emerged as major shareholders in Venn Life Sciences as part of its merger with Open Orphan.
The company announced last week that it has raised £4.5 million (€5 million) from investors to fund the reverse takeover of Dublin-based Open Orphan.
According to regulatory filings on Friday, Miton Asset Management and Crux Asset Management will each own 3.5 per cent of Open Orphan after the fundraising is complete. Livingbridge, a...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
EY reports €393m revenues in Republic of Ireland for 2021 financial year
Revenues in the Republic increased 9.5 per cent for the year up to June 2021 to €393 million, up from €359 million in the previous year